Cervomed INC Form 4 insider transactions

CervoMed Inc. director Marwan Sabbagh was granted options to purchase 8,100 shares of common stock as part of his compensation following his election to the board.

CervoMed Inc. Director Jeffrey V. Poulton was granted options to purchase 8,100 shares of common stock at an exercise price of $6.52 per share, vesting monthly over one year.

CervoMed Inc. director Jane H. Hollingsworth was granted options to purchase 8,100 shares of common stock at an exercise price of $6.52 per share, vesting monthly over one year, following her election to the board.

CervoMed Inc. has granted 8,100 stock options to Sylvie Gregoire, a newly elected director and 10% owner, as part of her compensation package.

William Elder, CFO, GC & Secretary of CervoMed Inc., reports purchasing and disposing of common stock on May 14, 2025.

Sylvie Gregoire, spouse of CervoMed Inc.'s CEO John Alam, reports acquisition of stock options.

William Robert Elder, CFO & GC of CervoMed Inc., reports the acquisition of 27,000 stock options on February 4, 2025, exercisable at $2.30, vesting monthly over 36 months.

Robert Joseph Cobuzzi Jr., Chief Operating Officer of CervoMed Inc., reports the acquisition of stock options.

Kelly Blackburn, SVP of Clinical Development at CervoMed Inc., reports the acquisition of stock options.

CervoMed Inc.'s CEO, John J. Alam, acquired 60,000 stock options on February 4, 2025, according to a Form 4 filing.

CervoMed's CFO and General Counsel, William Robert Elder, recently purchased 1,000 shares of the company's common stock in an open market transaction.

John J. Alam, CEO & President of CervoMed Inc., reports stock options granted to his spouse, Sylvie Gregoire, a non-employee director.

Joshua Boger, a director of CervoMed Inc., was granted options to purchase 5,750 shares of common stock on June 14, 2024, following his election to the board.

Director Sylvie Gregoire received stock options for 5,750 shares of CervoMed Inc. common stock following election to the board.

Director Jane H. Hollingsworth acquired stock options for 5,750 shares of CervoMed Inc. (CRVO) common stock on June 14, 2024, following her election to the board.

Jeffrey V. Poulton, a director of CervoMed Inc., acquired stock options for 5,750 shares of common stock on June 14, 2024, following his election to the board.

Director Sabbagh Marwan acquired stock options for 5,750 shares of CervoMed Inc. common stock on June 14, 2024, following election to the board.

Frank Zavrl, a director of CervoMed Inc., was granted options to purchase 5,750 shares of common stock on June 14, 2024, following his election to the board.

Director Joshua Boger exercised a pre-funded common stock purchase warrant to acquire shares of CervoMed Inc. common stock.